Hypertrophic And Keloid Scar Treatment Market
授權報價
| Single User License | $4,950 USD |
| Enterprise License | $5,950 USD |
| Corporate User License | $7,950 USD |
完整報告名稱與涵蓋範圍
Hypertrophic And Keloid Scar Treatment Market Size, Share & Trends Analysis Report By Scar Type (Hypertrophic, Keloid), By Product (Topical Products, Laser Products, Injectables), By End-use (Business to Business (B2B), Business to Consumers (B2C)), By Region, And Segment Forecasts, 2026 - 2033
報告摘要
Hypertrophic And Keloid Scar Treatment Market Summary
The global hypertrophic and keloid scar treatment market size was valued at USD 763.2 million in 2025 and is projected to grow from USD 842.7 million in 2026 to USD 1,680.2 million by 2033, at a CAGR of 10.4% from 2026 to 2033. Asia Pacific held the largest market share of 46.1% in 2025. The increase in the number of road accidents & burn cases, along with technological advancements and growing awareness regarding the availability of aesthetic surgery, are major factors boosting the industry adoption over the years.
The global increase in the number of road accidents & burn incidence is anticipated to boost the hypertrophic and keloid scar treatment industry. For instance, according to the Association for Safe International Road Travel, approximately 1.35 million people die in road accidents every year. Moreover, as per a similar source, in the U.S., 4.4 million people get seriously injured. The increasing global burden of acne and its long-term secondary effects are key drivers of growth in the hypertrophic and keloid scars industry. In February 2024, a landmark global epidemiology study was published in the Journal of the American Academy of Dermatology (JAAD) by Pierre Fabre Laboratories as part of the ALL-project initiative. This large-scale study surveyed 50,552 adults across 20 countries, representing over 50% of the world’s population, making it one of the most comprehensive assessments of acne prevalence and its societal impact.
The study found that global acne prevalence stands at 20.5%, meaning one in five individuals worldwide is affected. Prevalence is highest among adolescents and young adults (16-24 years) at 28.3% and remains high in adults aged 25-39 years at 19.3%. Women are more affected than men (23.6% vs. 17.5%), broadening the long-term consumer base for post-acne scar and pigmentation treatments.
Geographically, the highest prevalence rates were observed in Latin America (23.9%), East Asia (20.2%), Africa (18.5%), and the Middle East (16.1%), while Europe (9.7%) and Australia (10.8%) reported lower rates. Many high-prevalence regions overlap with populations predisposed to PIH and hypertrophic scarring, strengthening demand for targeted topical therapies.
Global Hypertrophic And Keloid Scar Treatment Market Report Segmentation
This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. Forthis study, Grand View Research has segmented the hypertrophic and keloid scar treatment market report based on scar type, product, end use, and region:
• Scar type Outlook (Revenue, USD Million, 2021 - 2033)
• Hypertrophic Scar
• Keloid Scar
• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Topical Products
o Silicone Sheets
o Creams
o Gels
o Others
• Laser Products
o Pulsed Dye Lasers
o CO2 Lasers
o Others
• Injectables
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Business to Business (B2B)
o Hospitals
o Clinics
• Business to Consumers (B2C)
o Pharmacies
o Online/E-commerce
o Hypermarkets &Supermarkets
o Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Thailand
• Latin America
o Brazil
o Argentina
• Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o UAE
o Kuwait
目錄 Table of Contents
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Scar Type
1.2.2. Product
1.2.3. End Use
1.2.4. Region scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Scar type outlook
2.2.2. Product outlook
2.2.3. End use outlook
2.2.4. Region outlook
2.3. Competitive Insights
Chapter 3. Hypertrophic & Keloid Scar Treatment Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Hypertrophic & Keloid Scar Treatment Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Hypertrophic & Keloid Scar Treatment Market: Scar Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Hypertrophic & Keloid Scar Treatment Market: Scar Type Movement Analysis
4.3. Hypertrophic & Keloid Scar Treatment Market by Scar Type Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.5. Hypertrophic Scar
4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Keloid Scar
4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Hypertrophic & Keloid Scar Treatment Market: Product Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Hypertrophic & Keloid Scar Treatment Market: Application Movement Analysis
5.3. Hypertrophic & Keloid Scar Treatment Market by Application Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.5. Topical Products
5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.2. Silicone Sheets
5.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.3. Creams
5.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.4. Gels
5.5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.5. Others
5.5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Laser Products
5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6.2. Pulsed Dye Lasers
5.6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6.3. CO2 Lasers
5.6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6.4. Others
5.6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Injectables
5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Hypertrophic & Keloid Scar Treatment Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Hypertrophic & Keloid Scar Treatment Market: End Use Movement Analysis
6.3. Hypertrophic & Keloid Scar Treatment Market by End Use Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.5. Business to Business (B2B)
6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.2. Hospitals
6.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.3. Clinics
6.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Business to Consumers (B2C)
6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.2. Pharmacies
6.6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.3. Online/E-commerce
6.6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.4. Hypermarkets &Supermarkets
6.6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.5. Others
6.6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Hypertrophic & Keloid Scar Treatment Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2025 & 2033
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
7.5.3. Mexico
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework/ reimbursement structure
7.6.4.3. Competitive scenario
7.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework/ reimbursement structure
7.6.5.3. Competitive scenario
7.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
7.6.6. Denmark
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework/ reimbursement structure
7.6.6.3. Competitive scenario
7.6.6.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework/ reimbursement structure
7.6.7.3. Competitive scenario
7.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
7.6.8. Norway
7.6.8.1. Key country dynamics
7.6.8.2. Regulatory framework/ reimbursement structure
7.6.8.3. Competitive scenario
7.6.8.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory framework/ reimbursement structure
7.7.5.3. Competitive scenario
7.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Regulatory framework/ reimbursement structure
7.7.6.3. Competitive scenario
7.7.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework/ reimbursement structure
7.8.1.3. Competitive scenario
7.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
7.8.2. Argentina
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework/ reimbursement structure
7.8.2.3. Competitive scenario
7.8.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Regulatory framework/ reimbursement structure
7.9.1.3. Competitive scenario
7.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Regulatory framework/ reimbursement structure
7.9.2.3. Competitive scenario
7.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Regulatory framework/ reimbursement structure
7.9.3.3. Competitive scenario
7.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Regulatory framework/ reimbursement structure
7.9.4.3. Competitive scenario
7.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Key Company Profiles
8.2.1. Smith & Nephew
8.2.1.1. Company Overview
8.2.1.2. Financial Performance
8.2.1.3. Product Benchmarking
8.2.1.4. Strategic Initiatives
8.2.2. Merz Pharmaceuticals, LLC
8.2.2.1. Company Overview
8.2.2.2. Financial Performance
8.2.2.3. Product Benchmarking
8.2.2.4. Strategic Initiatives
8.2.3. Sonoma Pharmaceuticals, Inc.
8.2.3.1. Company Overview
8.2.3.2. Financial Performance
8.2.3.3. Product Benchmarking
8.2.3.4. Strategic Initiatives
8.2.4. CCA Industries, Inc.
8.2.4.1. Company Overview
8.2.4.2. Financial Performance
8.2.4.3. Product Benchmarking
8.2.4.4. Strategic Initiatives
8.2.5. Newmedical Technology Inc.
8.2.5.1. Company Overview
8.2.5.2. Financial Performance
8.2.5.3. Product Benchmarking
8.2.5.4. Strategic Initiatives
8.2.6. Mölnlycke Health Care AB
8.2.6.1. Company Overview
8.2.6.2. Financial Performance
8.2.6.3. Product Benchmarking
8.2.6.4. Strategic Initiatives
8.2.7. Perrigo Company plc
8.2.7.1. Company Overview
8.2.7.2. Financial Performance
8.2.7.3. Product Benchmarking
8.2.7.4. Strategic Initiatives
8.2.8. Rejuvaskin/ Scar Heal Inc.
8.2.8.1. Company Overview
8.2.8.2. Financial Performance
8.2.8.3. Product Benchmarking
8.2.8.4. Strategic Initiatives
8.2.9. Alliance Pharma PLC
8.2.9.1. Company Overview
8.2.9.2. Financial Performance
8.2.9.3. Product Benchmarking
8.2.9.4. Strategic Initiatives
8.2.10. Hanson Medical, Inc.
8.2.10.1. Company Overview
8.2.10.2. Financial Performance
8.2.10.3. Product Benchmarking
8.2.10.4. Strategic Initiatives
8.2.11. Lumenis Be Ltd.
8.2.11.1. Company Overview
8.2.11.2. Financial Performance
8.2.11.3. Product Benchmarking
8.2.11.4. Strategic Initiatives
8.2.12. CYNOSURE
8.2.12.1. Company Overview
8.2.12.2. Financial Performance
8.2.12.3. Product Benchmarking
8.2.12.4. Strategic Initiatives
圖表清單 List of Tables & Figures
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America hypertrophic and keloid scar treatment market, by country, 2021 - 2033 (USD Million)
Table 4 North America hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 5 North America hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 6 North America hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 7 U.S. hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 8 U.S. hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 9 U.S. hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 10 Canada hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 11 Canada hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 12 Canada hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 13 Mexico hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 14 Mexico hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 15 Mexico hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 16 Europe hypertrophic and keloid scar treatment market, by country, 2021 - 2033 (USD Million)
Table 17 Europe hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 18 Europe hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 19 Europe hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 20 UK hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 21 UK hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 22 UK hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 23 Germany hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 24 Germany hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 25 Germany hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 26 France hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 27 France hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 28 France hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 29 Italy hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 30 Italy hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 31 Italy hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 32 Spain hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 33 Spain hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 34 Spain hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 35 Denmark hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 36 Denmark hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 37 Denmark hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 38 Sweden hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 39 Sweden hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 40 Sweden hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 41 Norway hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 42 Norway hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 43 Norway hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 44 Asia Pacific hypertrophic and keloid scar treatment market, by country, 2021 - 2033 (USD Million)
Table 45 Asia Pacific hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 46 Asia Pacific hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 47 Asia Pacific hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 48 Japan hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 49 Japan hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 50 Japan hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 51 China hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 52 China hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 53 China hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 54 India hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 55 India hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 56 India hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 57 Australia hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 58 Australia hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 59 Australia hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 60 South Korea hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 61 South Korea hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 62 South Korea hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 63 Thailand hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 64 Thailand hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 65 Thailand hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 66 Latin America hypertrophic and keloid scar treatment market, by country, 2021 - 2033 (USD Million)
Table 67 Latin America hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 68 Latin America hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 69 Latin America hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 70 Brazil hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 71 Brazil hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 72 Brazil hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 73 Argentina hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 74 Argentina hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 75 Argentina hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 76 Middle East & Africa hypertrophic and keloid scar treatment market, by country, 2021 - 2033 (USD Million)
Table 77 Middle East & Africa hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 78 Middle East & Africa hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 79 Middle East & Africa hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 80 South Africa hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 81 South Africa hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 82 South Africa hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 83 Saudi Arabia hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 84 Saudi Arabia hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 85 Saudi Arabia hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 86 UAE hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 87 UAE hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 88 UAE hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
Table 89 Kuwait hypertrophic and keloid scar treatment market, by scar type, 2021 - 2033 (USD Million)
Table 90 Kuwait hypertrophic and keloid scar treatment market, by product, 2021 - 2033 (USD Million)
Table 91 Kuwait hypertrophic and keloid scar treatment market, by end-use, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Hypertrophic & keloid scar treatment market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Scar type and product outlook (USD Million)
Fig. 10 End use outlook (USD Million)
Fig. 11 Competitive landscape
Fig. 12 Hypertrophic & keloid scar treatment market dynamics
Fig. 13 Hypertrophic & keloid scar treatment market: Porter’s five forces analysis
Fig. 14 Hypertrophic & keloid scar treatment market: PESTLE analysis
Fig. 15 Hypertrophic & keloid scar treatment market: Scar type segment dashboard
Fig. 16 Hypertrophic & keloid scar treatment market: Scar type market share analysis, 2025 & 2033
Fig. 17 Hypertrophic scar treatment market, 2021 - 2033 (USD Million)
Fig. 18 Keloid scar market, 2021 - 2033 (USD Million)
Fig. 19 Hypertrophic & keloid scar treatment market: Product segment dashboard
Fig. 20 Hypertrophic & keloid scar treatment market: Product market share analysis, 2025 & 2033
Fig. 21 Topical products market, 2021 - 2033 (USD Million)
Fig. 22 Silicone sheets market, 2021 - 2033 (USD Million)
Fig. 23 Creams market, 2021 - 2033 (USD Million)
Fig. 24 Gels market, 2021 - 2033 (USD Million)
Fig. 25 Others market, 2021 - 2033 (USD Million)
Fig. 26 Laser products market, 2021 - 2033 (USD Million)
Fig. 27 Pulsed dye lasers market, 2021 - 2033 (USD Million)
Fig. 28 CO2 lasers market, 2021 - 2033 (USD Million)
Fig. 29 Others market, 2021 - 2033 (USD Million)
Fig. 30 Injectables market, 2021 - 2033 (USD Million)
Fig. 31 Hypertrophic & keloid scar treatment market: End use segment dashboard
Fig. 32 Hypertrophic & keloid scar treatment market: End use market share analysis, 2025 & 2033
Fig. 33 Business-to-business (B2B) market, 2021 - 2033 (USD Million)
Fig. 34 Hospitals market, 2021 - 2033 (USD Million)
Fig. 35 Clinics market, 2021 - 2033 (USD Million)
Fig. 36 Business to consumers (B2C) market, 2021 - 2033 (USD Million)
Fig. 37 Pharmacies market, 2021 - 2033 (USD Million)
Fig. 38 Online/e-commerce market, 2021 - 2033 (USD Million)
Fig. 39 Hypermarkets & supermarkets market, 2021 - 2033 (USD Million)
Fig. 40 Others market, 2021 - 2033 (USD Million)
Fig. 41 Global hypertrophic & keloid scar treatment market: Regional movement analysis
Fig. 42 Global hypertrophic & keloid scar treatment market: Regional outlook and key takeaways
Fig. 43 Global hypertrophic & keloid scar treatment market share and leading players
Fig. 44 North America, by country
Fig. 45 North America
Fig. 46 North America market estimates and forecasts, 2021 - 2033
Fig. 47 U.S.
Fig. 48 U.S. market estimates and forecasts, 2021 - 2033
Fig. 49 Canada
Fig. 50 Canada market estimates and forecasts, 2021 - 2033
Fig. 51 Mexico
Fig. 52 Mexico market estimates and forecasts, 2021 - 2033
Fig. 53 Europe
Fig. 54 Europe market estimates and forecasts, 2021 - 2033
Fig. 55 UK
Fig. 56 UK market estimates and forecasts, 2021 - 2033
Fig. 57 Germany
Fig. 58 Germany market estimates and forecasts, 2021 - 2033
Fig. 59 France
Fig. 60 France market estimates and forecasts, 2021 - 2033
Fig. 61 Italy
Fig. 62 Italy market estimates and forecasts, 2021 - 2033
Fig. 63 Spain
Fig. 64 Spain market estimates and forecasts, 2021 - 2033
Fig. 65 Denmark
Fig. 66 Denmark market estimates and forecasts, 2021 - 2033
Fig. 67 Sweden
Fig. 68 Sweden market estimates and forecasts, 2021 - 2033
Fig. 69 Norway
Fig. 70 Norway market estimates and forecasts, 2021 - 2033
Fig. 71 Asia Pacific
Fig. 72 Asia Pacific market estimates and forecasts, 2021 - 2033
Fig. 73 China
Fig. 74 China market estimates and forecasts, 2021 - 2033
Fig. 75 Japan
Fig. 76 Japan market estimates and forecasts, 2021 - 2033
Fig. 77 India
Fig. 78 India market estimates and forecasts, 2021 - 2033
Fig. 79 Australia
Fig. 80 Australia market estimates and forecasts, 2021 - 2033
Fig. 81 South Korea
Fig. 82 South Korea market estimates and forecasts, 2021 - 2033
Fig. 83 Thailand
Fig. 84 Thailand market estimates and forecasts, 2021 - 2033
Fig. 85 Latin America
Fig. 86 Latin America market estimates and forecasts, 2021 - 2033
Fig. 87 Brazil
Fig. 88 Brazil market estimates and forecasts, 2021 - 2033
Fig. 89 Argentina
Fig. 90 Argentina market estimates and forecasts, 2021 - 2033
Fig. 91 Middle East and Africa
Fig. 92 Middle East and Africa market estimates and forecasts, 2021 - 2033
Fig. 93 South Africa
Fig. 94 South Africa market estimates and forecasts, 2021 - 2033
Fig. 95 Saudi Arabia
Fig. 96 Saudi Arabia market estimates and forecasts, 2021 - 2033
Fig. 97 UAE
Fig. 98 UAE market estimates and forecasts, 2021 - 2033
Fig. 99 Kuwait
Fig. 100 Kuwait market estimates and forecasts, 2021 - 2033
Fig. 101 Market share of key market players- Hypertrophic & keloid scar treatment market
提及公司
同分類最新報告（醫療器材）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Grand View Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們